Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record Methodology

Covered recipient · General Payments record

AGNES SERRANILLA-SONIDO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1093450454
CMS profile
11341691
Location
WAIPAHU, HI

General Payments · PY2025

$524.58

  • Reported across 17 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$524.58

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $524.58 17

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2025 $524.58 17

Payment records · PY2025 (17)

Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them

Program year 2025
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $25.91 12/15/2025 Food and Beverage Undisputed 06/30/2026 1228410823 CMS
ANI Pharmaceuticals, Inc. $14.67 07/10/2025 Food and Beverage Undisputed 06/30/2026 1248622470 CMS
AstraZeneca Pharmaceuticals LP $23.28 08/14/2025 Food and Beverage Undisputed 06/30/2026 1207298618 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.53 09/02/2025 Food and Beverage Undisputed 06/30/2026 1225783263 CMS
Bayer Healthcare Pharmaceuticals Inc. $8.76 10/01/2025 Food and Beverage Undisputed 06/30/2026 1225783271 CMS
Bayer Healthcare Pharmaceuticals Inc. $135.00 10/10/2025 Food and Beverage Undisputed 06/30/2026 1225783275 CMS
Bayer Healthcare Pharmaceuticals Inc. $7.63 10/14/2025 Food and Beverage Undisputed 06/30/2026 1225783268 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.84 11/20/2025 Food and Beverage Undisputed 06/30/2026 1225783279 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.56 12/11/2025 Food and Beverage Undisputed 06/30/2026 1225783283 CMS
Esperion Therapeutics, Inc. $21.32 08/18/2025 Food and Beverage Undisputed 06/30/2026 1243974862 CMS
Gilead Sciences, Inc. $31.79 08/26/2025 Food and Beverage Undisputed 06/30/2026 1234429070 CMS
Merck Sharp & Dohme LLC $22.45 11/07/2025 Food and Beverage Undisputed 06/30/2026 1238021568 CMS
Novo Nordisk Inc $0.85 10/15/2025 Food and Beverage Undisputed 06/30/2026 1188144815 CMS
Novo Nordisk Inc $9.55 10/15/2025 Food and Beverage Undisputed 06/30/2026 1188221749 CMS
Novo Nordisk Inc $1.42 10/15/2025 Food and Beverage Undisputed 06/30/2026 1188408203 CMS
Novo Nordisk Inc $121.85 10/28/2025 Food and Beverage Undisputed 06/30/2026 1188283213 CMS
Novo Nordisk Inc $26.17 11/17/2025 Food and Beverage Undisputed 06/30/2026 1188208007 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2025
Source files
Dataset page · Bulk file · PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.